Literature DB >> 28762787

On the "TRAIL" of a Killer: MMP12 in Lung Cancer.

Jesse Roman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28762787     DOI： 10.1164/rccm.201704-0668ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

1.  DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis.

Authors:  Tai-Lin Huang; Chuang-Rung Chang; Chih-Yen Chien; Gong-Kai Huang; Yi-Fan Chen; Li-Jen Su; Hsin-Ting Tsai; Yu-Sheng Lin; Fu-Min Fang; Chang-Han Chen
Journal:  Mol Oncol       Date:  2022-04-15       Impact factor: 7.449

2.  Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC).

Authors:  Jian Wang; Pengyi Yu; Judong Luo; Zhiqiang Sun; Jingping Yu; Jianlin Wang
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

3.  MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experiments.

Authors:  Minde Li; Lin Zhou; Shaoyang Li; Linchun Fang; Le Yang; Xiao Wu; Chenxing Yang; Youyuan Bao; Sihai Lan; Zhigao Tong; Suyue Zheng; Bin Tang; Erming Zeng; Shenhao Xie; Cheng Chen; Tao Hong
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.